Actively Recruiting
Preventing Mental Disorders in Young Adults with Low Self-Efficacy Through Cognitive-Behavioral Intervention: A Randomized Controlled Trial
Led by Health and Medical University Potsdam · Updated on 2024-12-18
378
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
H
Health and Medical University Potsdam
Lead Sponsor
G
German Research Foundation
Collaborating Sponsor
AI-Summary
What this Trial Is About
Low self-efficacy, or the belief in one's ability to perform tasks and achieve goals, is linked to higher risk of mental disorders such as anxiety, affective, and substance use disorders, especially in young adults. This randomized controlled trial aims to test whether a brief cognitive-behavioral intervention can increase general self-efficacy and prevent the onset of these mental disorders in young adults aged 18 to 30 years with low self-efficacy but no current mental disorder. The study will also explore if improvements in specific areas of self-efficacy influence overall self-efficacy and reduce mental health symptoms. Participants will be randomly assigned to either an intervention group or a control group. The intervention group will take part in six online group sessions (75-90 minutes each) led by a psychologist, focusing on enhancing self-efficacy through proven cognitive-behavioral techniques targeting mastery experiences, vicarious experiences, verbal persuasion, and emotional arousal. The control group will also meet in six group sessions but only discuss general psychological research unrelated to self-efficacy or cognitive-behavioral methods, without receiving any training. Throughout the study, participants will complete assessments at screening, baseline, after the intervention, and at 12-month follow-up, including structured interviews for mental disorders and various questionnaires measuring symptoms and self-efficacy. Additional ecological momentary assessments will collect real-time data. Researchers will analyze changes in self-efficacy, mental health symptoms, and the occurrence of mental disorders, while monitoring adherence and providing support such as homework reminders and access to psychologists for the intervention group.
CONDITIONS
Brief Title
Prevention of Mental Disorders Through Self-efficacy Interventions
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 30 years
- Low scores (24 or below) on the German General Self-Efficacy Scale, or up to 30 if needed for recruitment
- Ability to participate in the course, including German language proficiency and availability during the intervention period
You will not qualify if you...
- Diagnosis of anxiety, affective, or substance use disorder in the past 12 months (except nicotine dependence)
- Current psychological or psychopharmacological treatment or seeking such treatment
- Acute suicidality; individuals reporting this will be withdrawn and referred to treatment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or online) for eligibility assessment
Duration - 1 day
Participants complete baseline assessments including self-efficacy and clinical symptom measurements before starting the study.
1 baseline assessment visit
Duration - 6 weeks
Participants attend weekly group sessions over six weeks. The intervention group receives cognitive-behavioral self-efficacy training, while the control group participates in group discussions on psychological experiments without active training.
6 weekly group sessions (online)
Duration - 1 day
Participants complete assessments immediately after the group sessions to measure changes in self-efficacy and psychopathological symptoms.
1 post-intervention assessment visit
Duration - 1 day
Participants complete follow-up assessments 12 months after the post-intervention assessment to evaluate long-term effects on mental health and self-efficacy.
1 follow-up assessment visit
Trial Site Locations
Total: 1 location
1
Health and Medical University Potsdam
Potsdam, Brandenburg, Germany, 14471
Actively Recruiting
Research Team
E
Eva Asselmann, Prof. Dr. rer. nat. habil.
F
Felix D Gross, M. Sc. Psychology
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2